Peniskrebs: Unterschied zwischen den Versionen
K using Template:PhD |
K REFjournal uses <init> key |
||
| Zeile 115: | Zeile 115: | ||
In Japan, Norway, and Sweden, the risk of penile cancer is about the same as in the US (1 in 100,000 per year).<ref>{{REFjournal | In Japan, Norway, and Sweden, the risk of penile cancer is about the same as in the US (1 in 100,000 per year).<ref>{{REFjournal | ||
|last=Wallerstein | |last=Wallerstein | ||
| | |init=E | ||
|author-link=Edward Wallerstein | |||
|title=Circumcision. The uniquely American medical enigma | |title=Circumcision. The uniquely American medical enigma | ||
|journal=Urol | |journal=Urol Clin North Am | ||
|volume=12 | |volume=12 | ||
|issue=1 | |issue=1 | ||
| Zeile 135: | Zeile 136: | ||
Infection with HPV is associated with some penile cancers. A quadri-valent vaccine ([[Gardasil]]) to prevent infection by the four most common variants of HPV has been developed, successfully tested, and approved by the US [[Food and Drug Administration]] for females between the ages of 9 and 26, and as of 2009, males between the ages of 16 and 26.<ref name="titleAccess to articles : Nature Reviews Drug Discovery">{{REFjournal | Infection with HPV is associated with some penile cancers. A quadri-valent vaccine ([[Gardasil]]) to prevent infection by the four most common variants of HPV has been developed, successfully tested, and approved by the US [[Food and Drug Administration]] for females between the ages of 9 and 26, and as of 2009, males between the ages of 16 and 26.<ref name="titleAccess to articles : Nature Reviews Drug Discovery">{{REFjournal | ||
|last=Crum C | |last=Crum | ||
| | |init=C | ||
|last2=Jones | |||
|init2=C | |||
|last3=Kirkpatrick | |||
|init3=P | |||
|title=Quadrivalent human papillomavirus recombinant vaccine | |title=Quadrivalent human papillomavirus recombinant vaccine | ||
|journal=Nature reviews. Drug discovery | |journal=Nature reviews. Drug discovery | ||